本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ORUKA THERAPEUTICS INC

95.93
+3.553.84%
盤後95.930.00000.00%19:58 EDT
成交量:77.39萬
成交額:7,390.71萬
市值:63.51億
市盈率:-47.39
高:97.48
開:92.56
低:92.55
收:92.38
52周最高:115.52
52周最低:14.67
股本:6,620.97萬
流通股本:5,688.40萬
量比:1.23
換手率:1.36%
股息:- -
股息率:- -
每股收益(TTM):-2.0242
每股收益(LYR):-1.8483
淨資產收益率:-18.23%
總資產收益率:-12.95%
市淨率:5.71
市盈率(LYR):-51.90

資料載入中...

2026/09/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/24

重要事件披露

Form 8-K - Current report
2026/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/10

重要事件披露

Form 8-K - Current report
2026/07/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/05

重要事件披露

Form 8-K - Current report
2026/06/01

重要事件披露

Form 8-K - Current report
2026/05/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]